iRhythm director awarded 1,573 RSUs in stock grant
iRhythm Holdings director Cathleen Noel Bairey Merz received an equity award of 1,573 shares of Common Stock through restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
iRhythm Holdings director Cathleen Noel Bairey Merz received an equity award of 1,573 shares of Common Stock through restricted stock units. The grant was made at no cash cost to her and is a form of stock-based compensation rather than an open-market purchase.
Each RSU converts into one iRhythm share when it vests. The units vest on the earlier of one year after the grant date or the company’s next annual meeting. After this award, she directly holds 10,546 shares of iRhythm common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,573 | $0.00 | $0.00 |
Footnotes (1)
- F1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
contingent right financial
annual meeting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did iRhythm Holdings (IRTC) disclose in this Form 4 filing?
When do the newly granted iRhythm (IRTC) RSUs vest for the director?
Is the iRhythm (IRTC) Form 4 transaction an open-market stock purchase?
AI-generated analysis. How Rhea-AI works. Not financial advice.